Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Outset Medical Inc.

    NASDAQ: OM · Real-Time Price · USD
    18.96
    -1.17 (-5.81%)
    At close: Jun 27, 2025, 3:59 PM
    19.07
    0.55%
    After-hours: Jun 27, 2025, 05:50 PM EDT

    Outset Medical Statistics

    Share Statistics

    Outset Medical has 17.72M shares outstanding. The number of shares has increased by 0.16% in one year.

    Shares Outstanding

    n/a
    		 17.72M

    Shares Change (YoY)

    n/a
    		 0.16%

    Shares Change (QoQ)

    n/a
    		 2.55%

    Owned by Institutions (%)

    n/a
    		 2.7%

    Shares Floating

    n/a
    		 16.94M

    Failed to Deliver (FTD) Shares

    n/a
    		 1

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 1.01M, so 5.72% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.01M

    Short % of Shares Out

    n/a
    		 5.72%

    Short % of Float

    n/a
    		 5.79%

    Short Ratio (days to cover)

    n/a
    		 3.4

    Valuation Ratios

    The PE ratio is -6.76 and the forward PE ratio is -5.24. Outset Medical's PEG ratio is 0.23.

    PE Ratio

    n/a
    		 -6.76

    Forward PE

    n/a
    		 -5.24

    PS Ratio

    n/a
    		 7.61

    Forward PS

    n/a
    		 1.6

    PB Ratio

    n/a
    		 32.25

    P/FCF Ratio

    n/a
    		 -7.38

    PEG Ratio

    n/a
    		 0.23
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Outset Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.69, with a Debt / Equity ratio of 7.53.

    Current Ratio

    n/a
    		 5.69

    Quick Ratio

    n/a
    		 4.38

    Debt / Equity

    n/a
    		 7.53

    Debt / EBITDA

    n/a
    		 -2.06

    Debt / FCF

    n/a
    		 -1.72

    Interest Coverage

    n/a
    		 -4.75

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $321,155.37

    Profits Per Employee

    n/a
    		 $-361,514.12

    Employee Count

    n/a
    		 354

    Asset Turnover

    n/a
    		 0.41

    Inventory Turnover

    n/a
    		 1.27

    Taxes

    Income Tax

    n/a
    		 491K

    Effective Tax Rate

    n/a
    		 -0.39%

    Stock Price Statistics

    The stock price has increased by -67.17% in the last 52 weeks. The beta is 2.14, so Outset Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.14

    52-Week Price Change

    n/a
    		 -67.17%

    50-Day Moving Average

    n/a
    		 16.65

    200-Day Moving Average

    n/a
    		 12.93

    Relative Strength Index (RSI)

    n/a
    		 51.5

    Average Volume (20 Days)

    n/a
    		 256,553

    Income Statement

    In the last 12 months, Outset Medical had revenue of 113.69M and earned -127.98M in profits. Earnings per share was -2.46.

    Revenue

    n/a
    		 113.69M

    Gross Profit

    n/a
    		 38.56M

    Operating Income

    n/a
    		 -113.38M

    Net Income

    n/a
    		 -127.98M

    EBITDA

    n/a
    		 -97.89M

    EBIT

    n/a
    		 -103.61M

    Earnings Per Share (EPS)

    n/a
    		 -2.46
    Full Income Statement

    Balance Sheet

    The company has 124.01M in cash and 201.86M in debt, giving a net cash position of -77.84M.

    Cash & Cash Equivalents

    n/a
    		 124.01M

    Total Debt

    n/a
    		 201.86M

    Net Cash

    n/a
    		 -77.84M

    Retained Earnings

    n/a
    		 -1.09B

    Total Assets

    n/a
    		 301.21M

    Working Capital

    n/a
    		 252.34M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -116.3M and capital expenditures -912K, giving a free cash flow of -117.22M.

    Operating Cash Flow

    n/a
    		 -116.3M

    Capital Expenditures

    n/a
    		 -912K

    Free Cash Flow

    n/a
    		 -117.22M

    FCF Per Share

    n/a
    		 -2.26
    Full Cash Flow Statement

    Margins

    Gross margin is 33.92%, with operating and profit margins of -99.72% and -112.57%.

    Gross Margin

    n/a
    		 33.92%

    Operating Margin

    n/a
    		 -99.72%

    Pretax Margin

    n/a
    		 -112.13%

    Profit Margin

    n/a
    		 -112.57%

    EBITDA Margin

    n/a
    		 -86.1%

    EBIT Margin

    n/a
    		 -99.72%

    FCF Margin

    n/a
    		 -103.1%

    Dividends & Yields

    OM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for OM is $33, which is 74.1% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $33

    Price Target Difference

    n/a
    		 74.1%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 20, 2025. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Mar 20, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -3.24

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist